Millie
your market intelligence analyst
Search Results
3,586 results
Your search is now limited to «Company News in Respiratory Diseases» expert search.
ENDPOINTS 10/13/2019 16:54
Pfizer takes aim at a flagship franchise at Sanofi and Regeneron — and scores a few direct hits – Endpoints News.
More from ENDPOINTS:
Benzinga 10/13/2019 16:33
Biotech stocks continued to languish for a third straight week. Negative broader market sentiment and company-specific weakness weighed down on the sector. Pfenex Inc (NYSE: ) received for its biosimilar to Amgen, Inc. (NASDAQ: )'s Forteo, and Australian biotech Clinuvel Pharmaceuticals Ltd (OTC: )'s Scenesse to treat erythropoietic protoporphyria was also given the go-ahead by the regulatory agency. The week also saw the listing of two biotechs following their initial public offerings. The following are some of the key catalysts for biotech stocks in the upcoming week. Conferences. American Academy of Ophthalmology (AAO) 2019: Oct. 12-15 in San Francisco, California. International Congress And Exhibition on Endocrine And Diabetic Complicatio.
More from Benzinga:
PR Newswire 10/13/2019 14:54
NEW YORK, Oct. 13, 2019 /PRNewswire/ -- Allegiant Travel Company (ALGT) Lifshitz & Miller announces investigation into possible securities laws in connection with a CBS News 60 Minutes segment criticizing Allegiant's safety and maintenance records. If you are a ALGT investor, and would...
More from PR Newswire:
Reuters.com 10/13/2019 10:19
The J&J vaccine will complement another vaccine manufactured by Merck, which has been administered to more than 225,000 people.
More from Reuters.com:
24/7 Wall Street 10/13/2019 06:50
Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
More from 24/7 Wall Street:
(MENAFN - PR Newswire) NEW YORK, Oct. 13, 2019 /PRNewswire/ -- Allegiant Travel Company (ALGT) Lifshitz & Millerannounces investigation into possible securities laws in conne...
More from Middle East North Africa Financial Network (MENAFN):
Motley Fool 10/12/2019 12:16
But the decision between these two big healthcare stocks involves more than just looking at the areas where Gilead and Johnson & Johnson compete directly against each other.
More from Motley Fool:
NASDAQ 10/12/2019 12:16
But the decision between these two big healthcare stocks involves more than just looking at the areas where Gilead and Johnson & Johnson compete directly against each other.
More from NASDAQ:
Business Wire 10/12/2019 04:45
Pfizer recently announced positive top-line results from the companion Phase 3 study from the JADE program (JADE MONO-2), suggesting similar positive safety and efficacy results.
More from Business Wire:
PMLiVE 10/12/2019 04:08
Nawal Peacock By unleashing the potential of our people and our portfolio, Amgen has a bold ambition to bend the curve for patients and the European healthcare system.
More from PMLiVE:
ETHealthWorld (India) 10/12/2019 02:00
Lilly acquired Reyvow, formerly called lasmiditan , in a deal worth about $960 million when it bought CoLucid Pharmaceuticals Inc in early 2017.
More from ETHealthWorld (India):
Reuters.com 10/11/2019 17:31
Teva loses last-minute bid to be tried separately in landmark opioid case.
More from Reuters.com:
Seeking Alpha 10/11/2019 17:24
Pfizer (PFE) announced that it had licensed an antisense drug from Akcea Therapeutics (AKCA), which is a majority-owned affiliate of Ionis Pharmaceuticals (IONS) and Pfizer.
More from Seeking Alpha:
Hemophilia Federation of America and National Hemophilia Foundation continue to follow up on issues arising from Genentech’s recent announcement regarding reports of particulate matter in vials of Hemlibra.
More from Hemophilia Federation of America:
FiercePharmaManufacturing 10/11/2019 16:08
Lilly scores FDA nod for new migraine drug Reyvow.
More from FiercePharmaManufacturing:
CNBC - Business 10/11/2019 15:24
FDA approves new Eli Lilly drug to 'resolve' migraine pain in two hours.
More from CNBC - Business:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications